Skip to main content
Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
45.95
+0.05 (0.11%)
At close: Apr 28, 2026, 4:00 PM EDT
45.65
-0.30 (-0.65%)
Pre-market: Apr 29, 2026, 8:21 AM EDT

Sanofi Revenue

Sanofi had revenue of 11.24B EUR in the quarter ending March 31, 2026, with 6.02% growth. This brings the company's revenue in the last twelve months to 47.35B, up 8.18% year-over-year. In the year 2025, Sanofi had annual revenue of 46.72B with 5.49% growth.

Revenue (ttm)
47.35B EUR
Revenue Growth
+8.18%
P/S Ratio
2.04
Revenue / Employee
632,686 EUR
Employees
74,846
Market Cap
111.55B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202546.72B2.43B5.49%
Dec 31, 202444.29B3.18B7.73%
Dec 31, 202341.11B805.00M2.00%
Dec 31, 202240.30B1.13B2.88%
Dec 31, 202139.18B1.81B4.83%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Merck & Co. 65.01B
Pfizer 62.58B
AbbVie 61.16B
AstraZeneca 58.74B
Novartis AG 56.67B
Novo Nordisk 48.59B
Bristol-Myers Squibb Company 48.19B
GSK plc 43.97B
Revenue Rankings

SNY News

More News